DCOne as an Allogeneic Cell-based Vaccine for Multiple Myeloma-Reference-Cited by-同舟云学术

DCOne as an Allogeneic Cell-based Vaccine for Multiple Myeloma

Published:2017-11 Issue:9 Volume:40 Page:315-322
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Leaf Rebecca Karp,Stroopinsky Dina,Pyzer Athalia R.,Kruisbeek Ada M.,van Wetering Sandra,Washington Abigail,Ephraim Adam,Cole Leandra,Morin Adam,Jain Salvia,Nahas Myrna R.,Apel Arik,Arnason Jon,Hamdan Ayad,Rosenblatt Jacalyn,Avigan David

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference29 articles.

1. Lenalidomide in multiple myeloma;Richardson;Expert Rev Anticancer Ther,2006

2. Proteasome inhibitors in the treatment of multiple myeloma;Shah;Leukemia,2009

3. Autologous transplantation and maintenance therapy in multiple myeloma;Palumbo;N Engl J Med,2014

4. Targeting CD38 with daratumumab monotherapy in multiple myeloma;Lokhorst;N Engl J Med,2015

5. Clinical efficacy and management of monoclonal antibodies targeting CD38 and SLAMF7 in multiple myeloma;van de Donk;Blood,2016

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances and challenges in anti-cancer vaccines for multiple myeloma;Frontiers in Immunology;2024-08-01

2. Advancements in microenvironment-based therapies: transforming the landscape of multiple myeloma treatment;Frontiers in Oncology;2024-07-17

3. Nanomaterial Delivery Vehicles for the Development of Neoantigen Tumor Vaccines for Personalized Treatment;Molecules;2024-03-25

4. Extracellular Vesicles in Multiple Myeloma—Cracking the Code to a Better Understanding of the Disease;Cancers;2022-11-14

5. Update on the Role and Utility of Extracellular Vesicles in Hematological Malignancies;Stem Cells;2022-04-20